NR566 - ADVANCED PHARMACOLOGY
OBJECTIVE ASSESSMENT - EXAM
NR 566 / NR566 Final Exam
Qs & Ans (Latest 2026/2027):
Advanced Pharmacology for
Care of the Family
Verified Answers | 2026/2027 Edition
50 100% 2026/2027
QUESTIONS VERIFIED ANSWERS EDITION
TOPICS COVERED
Principles of Pharmacology Cardiovascular & Renal Pharmacotherapy
Endocrine & Metabolic Pharmacotherapy Infectious Disease Pharmacotherapy
Neurologic, Psychiatric & Pain Pharmacotherapy Pharmacokinetics & Drug Interactions
COVER PAGE - 1
, Q1 Question 1 of 50
Q1. A 58-year-old male with hypertension is prescribed lisinopril 10 mg daily. He asks
the nurse practitioner why he must take the medication every day rather than only when
his blood pressure feels high. The nurse practitioner explains that this dosing schedule
is necessary because lisinopril has which pharmacokinetic property?
A. A long elimination half-life that maintains steady-state plasma levels with daily dosing
B. A rapid onset of action that requires frequent administration to sustain effects
C. A high first-pass metabolism that necessitates multiple daily doses
D. A narrow therapeutic index that demands precise timing to avoid toxicity
Correct Answer: A
Rationale:
Lisinopril has an elimination half-life of approximately 12 hours, allowing once-daily dosing to maintain
therapeutic plasma concentrations. Option B is incorrect because rapid onset does not require frequent
dosing; option C is incorrect because lisinopril is not highly metabolized by first-pass effect; option D is
incorrect because ACE inhibitors do not have a narrow therapeutic index.
Q2 Question 2 of 50
Q2. A 42-year-old woman with a history of peptic ulcer disease is started on a proton
pump inhibitor. The nurse practitioner explains that the medication should be taken 30
minutes before breakfast because the drug's mechanism of action depends on what
physiological state?
A. Activation of proton pumps during the fasting state to maximize drug binding
B. Suppression of gastric acid secretion during the postprandial alkaline tide
C. Peak plasma drug concentration coinciding with maximal gastric acid output
D. Reduced first-pass hepatic metabolism when taken on an empty stomach
Correct Answer: A
Rationale:
Proton pump inhibitors are prodrugs activated in the acidic canaliculi of parietal cells and bind irreversibly to
active proton pumps. Taking the medication before a meal ensures it is present when pumps are activated
by food stimulation. Option B confuses the mechanism; option C is incorrect because peak plasma is not the
primary factor; option D is irrelevant to PPI pharmacokinetics.
NR566 - 2026/2027 | Passing Score: 80% | Page 2 of 30
SECTION 1 | Principles of Pharmacology | Q1-Q10 | NR566 2026/2027
, Q3 Question 3 of 50
Q3. A 67-year-old patient with atrial fibrillation is prescribed warfarin 5 mg daily. The
nurse practitioner monitors the patient's INR closely because warfarin has a low
therapeutic index. What is the primary clinical implication of a low therapeutic index?
A. The dose that produces toxicity is close to the dose that produces the desired
therapeutic effect
B. The drug requires loading doses to achieve therapeutic levels rapidly
C. The medication must be administered intravenously to ensure bioavailability
D. The drug exhibits nonlinear pharmacokinetics at standard doses
Correct Answer: A
Rationale:
A low therapeutic index means the toxic dose is close to the effective dose, necessitating careful monitoring.
Option B describes drugs with long half-lives; option C is unrelated to therapeutic index; option D describes
capacity-limited metabolism seen in drugs like phenytoin, not warfarin.
Q4 Question 4 of 50
Q4. A 35-year-old patient taking oral contraceptives is prescribed rifampin for latent
tuberculosis infection. The nurse practitioner warns the patient that rifampin may
reduce contraceptive efficacy. This interaction occurs primarily through which
pharmacokinetic mechanism?
A. Induction of hepatic cytochrome P450 enzymes, increasing metabolism of estrogen
B. Competition for plasma protein binding sites, increasing free hormone levels
C. Inhibition of intestinal P-glycoprotein, reducing drug absorption
D. Alteration of gastric pH, affecting dissolution of the oral contraceptive
Correct Answer: A
Rationale:
Rifampin is a potent inducer of CYP3A4 and CYP2C9, accelerating estrogen metabolism and reducing
contraceptive efficacy. Option B would increase, not decrease, effect; option C is incorrect as rifampin does
not inhibit P-glycoprotein; option D is irrelevant to this interaction.
NR566 - 2026/2027 | Passing Score: 80% | Page 3 of 30
SECTION 1 | Principles of Pharmacology | Q1-Q10 | NR566 2026/2027
OBJECTIVE ASSESSMENT - EXAM
NR 566 / NR566 Final Exam
Qs & Ans (Latest 2026/2027):
Advanced Pharmacology for
Care of the Family
Verified Answers | 2026/2027 Edition
50 100% 2026/2027
QUESTIONS VERIFIED ANSWERS EDITION
TOPICS COVERED
Principles of Pharmacology Cardiovascular & Renal Pharmacotherapy
Endocrine & Metabolic Pharmacotherapy Infectious Disease Pharmacotherapy
Neurologic, Psychiatric & Pain Pharmacotherapy Pharmacokinetics & Drug Interactions
COVER PAGE - 1
, Q1 Question 1 of 50
Q1. A 58-year-old male with hypertension is prescribed lisinopril 10 mg daily. He asks
the nurse practitioner why he must take the medication every day rather than only when
his blood pressure feels high. The nurse practitioner explains that this dosing schedule
is necessary because lisinopril has which pharmacokinetic property?
A. A long elimination half-life that maintains steady-state plasma levels with daily dosing
B. A rapid onset of action that requires frequent administration to sustain effects
C. A high first-pass metabolism that necessitates multiple daily doses
D. A narrow therapeutic index that demands precise timing to avoid toxicity
Correct Answer: A
Rationale:
Lisinopril has an elimination half-life of approximately 12 hours, allowing once-daily dosing to maintain
therapeutic plasma concentrations. Option B is incorrect because rapid onset does not require frequent
dosing; option C is incorrect because lisinopril is not highly metabolized by first-pass effect; option D is
incorrect because ACE inhibitors do not have a narrow therapeutic index.
Q2 Question 2 of 50
Q2. A 42-year-old woman with a history of peptic ulcer disease is started on a proton
pump inhibitor. The nurse practitioner explains that the medication should be taken 30
minutes before breakfast because the drug's mechanism of action depends on what
physiological state?
A. Activation of proton pumps during the fasting state to maximize drug binding
B. Suppression of gastric acid secretion during the postprandial alkaline tide
C. Peak plasma drug concentration coinciding with maximal gastric acid output
D. Reduced first-pass hepatic metabolism when taken on an empty stomach
Correct Answer: A
Rationale:
Proton pump inhibitors are prodrugs activated in the acidic canaliculi of parietal cells and bind irreversibly to
active proton pumps. Taking the medication before a meal ensures it is present when pumps are activated
by food stimulation. Option B confuses the mechanism; option C is incorrect because peak plasma is not the
primary factor; option D is irrelevant to PPI pharmacokinetics.
NR566 - 2026/2027 | Passing Score: 80% | Page 2 of 30
SECTION 1 | Principles of Pharmacology | Q1-Q10 | NR566 2026/2027
, Q3 Question 3 of 50
Q3. A 67-year-old patient with atrial fibrillation is prescribed warfarin 5 mg daily. The
nurse practitioner monitors the patient's INR closely because warfarin has a low
therapeutic index. What is the primary clinical implication of a low therapeutic index?
A. The dose that produces toxicity is close to the dose that produces the desired
therapeutic effect
B. The drug requires loading doses to achieve therapeutic levels rapidly
C. The medication must be administered intravenously to ensure bioavailability
D. The drug exhibits nonlinear pharmacokinetics at standard doses
Correct Answer: A
Rationale:
A low therapeutic index means the toxic dose is close to the effective dose, necessitating careful monitoring.
Option B describes drugs with long half-lives; option C is unrelated to therapeutic index; option D describes
capacity-limited metabolism seen in drugs like phenytoin, not warfarin.
Q4 Question 4 of 50
Q4. A 35-year-old patient taking oral contraceptives is prescribed rifampin for latent
tuberculosis infection. The nurse practitioner warns the patient that rifampin may
reduce contraceptive efficacy. This interaction occurs primarily through which
pharmacokinetic mechanism?
A. Induction of hepatic cytochrome P450 enzymes, increasing metabolism of estrogen
B. Competition for plasma protein binding sites, increasing free hormone levels
C. Inhibition of intestinal P-glycoprotein, reducing drug absorption
D. Alteration of gastric pH, affecting dissolution of the oral contraceptive
Correct Answer: A
Rationale:
Rifampin is a potent inducer of CYP3A4 and CYP2C9, accelerating estrogen metabolism and reducing
contraceptive efficacy. Option B would increase, not decrease, effect; option C is incorrect as rifampin does
not inhibit P-glycoprotein; option D is irrelevant to this interaction.
NR566 - 2026/2027 | Passing Score: 80% | Page 3 of 30
SECTION 1 | Principles of Pharmacology | Q1-Q10 | NR566 2026/2027
